All AMGN Content

Amgen Inc. (AMGN) Amgen Announces Positive Topline Phase 3 Results For Subcutaneous Tepezza In Adults Living With Moderate-To-Severe Active Thyroid Eye Disease

Amgen Inc. (NASDAQ: AMGN) FY 2026 Other Release

April 6, 20261 min read

Amgen Inc. (AMGN) 2026 J.P. Morgan Healthcare Conference

Amgen Inc. (NASDAQ: AMGN) FY 2026 Corporate Conference

March 31, 20261 min read

Amgen Inc. (AMGN) Repatha® Cuts Risk Of First Major Cardiovascular Events By 31% In High-risk Patients Without Known Significant Atherosclerosis

Amgen Inc. (NASDAQ: AMGN) FY 2026 Other Release

March 29, 20261 min read

Amgen Inc. (AMGN) Leerink Partners 2026 Global Healthcare Conference

Amgen Inc. (NASDAQ: AMGN) FY 2026 Corporate Conference

March 5, 20261 min read

Amgen Inc. (AMGN) Dividend Update

Amgen Inc. (NASDAQ: AMGN) Q2 2026 Dividend Update

March 4, 20261 min read

Amgen Inc. (AMGN) 46th Annual TD Cowen Health Care Conference

Amgen Inc. (NASDAQ: AMGN) FY 2026 Corporate Conference

February 24, 20261 min read

Amgen Inc. (AMGN) Sec Form 8K

Amgen Inc. (NASDAQ: AMGN) Sec Form 8K

February 20, 20261 min read

Amgen Inc. (AMGN) Sec Form 10K

Amgen Inc. (NASDAQ: AMGN) Sec Form 10K

February 14, 20261 min read

Amgen Inc. (AMGN) Summit Meeting

Amgen Inc. (NASDAQ: AMGN) Summit Meeting

February 14, 20261 min read

Amgen Inc. (AMGN) Q4 2025 Earnings Call Transcript

Amgen Inc. (NASDAQ: AMGN) Q4 2025 Earnings Call dated Feb. 03, 2026 Corporate Participants: Casey Capparelli — Vice President, Investor Relations Robert A. Bradway —…

February 4, 202648 min read